Diabetes, a heavy cost

To pay rent or buy an insulin dose? In recent years, insulin prices in some Western countries have become a big topic. How does the pharmaceutical industry profit off people with this condition? How do patients cope? Investigating the workings of the pharmaceutical industry and their take on the treatment of diabetes type 2 and type 1 as well. The metabolic disorder of diabetes is an $850-billion industry. Rising prices are attributed to improvements to the medical effect—yet, independent scientific studies refute such claims. How can the patients and doctors increase the availability and effectiveness of treatment when the global market is controlled by only three companies? (Academia Film Olomouc)